BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12527715)

  • 1. Expression of platelet-derived growth factor-AA is associated with tumor progression in osteosarcoma.
    Sulzbacher I; Birner P; Trieb K; Träxler M; Lang S; Chott A
    Mod Pathol; 2003 Jan; 16(1):66-71. PubMed ID: 12527715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma.
    Sulzbacher I; Träxler M; Mosberger I; Lang S; Chott A
    Mod Pathol; 2000 Jun; 13(6):632-7. PubMed ID: 10874667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma.
    Sulzbacher I; Birner P; Träxler M; Marberger M; Haitel A
    Am J Clin Pathol; 2003 Jul; 120(1):107-12. PubMed ID: 12866380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of platelet-derived growth factor-alpha receptor in human osteosarcoma is not a predictor of outcome.
    Sulzbacher I; Birner P; Dominkus M; Pichlhofer B; Mazal PR
    Pathology; 2010 Dec; 42(7):664-8. PubMed ID: 21080877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.
    Kloen P; Gebhardt MC; Perez-Atayde A; Rosenberg AE; Springfield DS; Gold LI; Mankin HJ
    Cancer; 1997 Dec; 80(12):2230-9. PubMed ID: 9404699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of growth factors and their receptors in human osteosarcomas. Immunohistochemical detection of epidermal growth factor, platelet-derived growth factor and their receptors: its correlation with proliferating activities and p53 expression.
    Oda Y; Wehrmann B; Radig K; Walter H; Röse I; Neumann W; Roessner A
    Gen Diagn Pathol; 1995 Oct; 141(2):97-103. PubMed ID: 8548600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of platelet-derived growth factor-AA and platelet-derived growth factor-alpha receptor in ameloblastomas.
    Sulzbacher I; Wick N; Pichlhofer B; Mazal PR
    J Oral Pathol Med; 2008 Apr; 37(4):235-40. PubMed ID: 18284546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma.
    Lee JA; Jung JS; Kim DH; Lim JS; Kim MS; Kong CB; Song WS; Cho WH; Jeon DG; Lee SY; Koh JS
    Pediatr Blood Cancer; 2011 May; 56(5):738-43. PubMed ID: 21370405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.
    Kilpatrick SE; Geisinger KR; King TS; Sciarrotta J; Ward WG; Gold SH; Bos GD
    Mod Pathol; 2001 Dec; 14(12):1277-83. PubMed ID: 11743051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.
    Kubo T; Piperdi S; Rosenblum J; Antonescu CR; Chen W; Kim HS; Huvos AG; Sowers R; Meyers PA; Healey JH; Gorlick R
    Cancer; 2008 May; 112(10):2119-29. PubMed ID: 18338812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.
    Yang QC; Zeng BF; Dong Y; Shi ZM; Jiang ZM; Huang J
    Jpn J Clin Oncol; 2007 Feb; 37(2):127-34. PubMed ID: 17237146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
    Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
    Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
    Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
    Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of platelet-derived growth factor and its receptors in soft tissue malignant fibrous histiocytoma.
    Yamamoto T; Akisue T; Marui T; Fujita I; Matsumoto K; Kawamoto T; Hitora T; Nakatani T; Nagira K; Kurosaka M
    Anticancer Res; 2003; 23(5b):4325-8. PubMed ID: 14666646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.